Literature DB >> 2560112

Comparative pathogenesis of three strains of pseudorabies virus in pigs.

J M Pol1, A L Gielkens, J T van Oirschot.   

Abstract

Three strains of pseudorabies virus were intranasally inoculated into 10-week-old pigs and the pathogenesis of the infection was compared. Virulent NIA-3 virus caused widespread necrotic lesions in nasal mucosa, rapidly invading the stroma and infecting axons of olfactory nerves within 24 h of inoculation. Intermediate virulent virus 2.4N3A, a mutant strain derived from NIA-3, caused less necrosis of the mucosa and did not reach axons of olfactory nerves until 72 h after inoculation. Bartha virus strain K, a non-virulent virus strain, caused a mild infection in the superficial layers of nasal epithelium. Viral antigens were not detected in stromal fibroblasts or nerve cells. The inflammatory response of the pigs varied with the virus strains used: after infection with NIA-3 virus mainly neutrophils infiltrated the nasal mucosa, whereas after infection with 2.4N3A virus and Bartha virus, mainly macrophages and lymphocytes infiltrated the nasal mucosa.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2560112     DOI: 10.1016/0882-4010(89)90039-9

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  15 in total

1.  Growth, physicochemical properties, and morphogenesis of Chinese wild-type PRV Fa and its gene-deleted mutant strain PRV SA215.

Authors:  Ling Zhu; Yue Yi; Zhiwen Xu; Lu Cheng; Shanhu Tang; Wanzhu Guo
Journal:  Virol J       Date:  2011-06-04       Impact factor: 4.099

2.  Role of pseudorabies virus Us9, a type II membrane protein, in infection of tissue culture cells and the rat nervous system.

Authors:  A D Brideau; J P Card; L W Enquist
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Age-Dependent Differences in Pseudorabies Virus Neuropathogenesis and Associated Cytokine Expression.

Authors:  Sara Verpoest; Brigitte Cay; Herman Favoreel; Nick De Regge
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

4.  Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice.

Authors:  B Peeters; J Pol; A Gielkens; R Moormann
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

5.  Rescue of very virulent and mosaic infectious bursal disease virus from cloned cDNA: VP2 is not the sole determinant of the very virulent phenotype.

Authors:  H J Boot; A A ter Huurne; A J Hoekman; B P Peeters; A L Gielkens
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Exchange of the C-terminal part of VP3 from very virulent infectious bursal disease virus results in an attenuated virus with a unique antigenic structure.

Authors:  Hein J Boot; A Agnes H M ter Huurne; Arjan J W Hoekman; Jan M Pol; Arno L J Gielkens; Ben P H Peeters
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Glycoprotein D-negative pseudorabies virus can spread transneuronally via direct neuron-to-neuron transmission in its natural host, the pig, but not after additional inactivation of gE or gI.

Authors:  W Mulder; J Pol; T Kimman; G Kok; J Priem; B Peeters
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  Nucleocapsid protein N of Lelystad virus: expression by recombinant baculovirus, immunological properties, and suitability for detection of serum antibodies.

Authors:  J J Meulenberg; R J Bende; J M Pol; G Wensvoort; R J Moormann
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

9.  The US3 Protein of Pseudorabies Virus Drives Viral Passage across the Basement Membrane in Porcine Respiratory Mucosa Explants.

Authors:  Jochen A S Lamote; Sarah Glorieux; Hans J Nauwynck; Herman W Favoreel
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

10.  Pseudorabies virus infectivity for swine skin characterized in vitro.

Authors:  E R Tulman; A E Garmendia
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.